Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TW9N
|
|||
| Former ID |
DNC008727
|
|||
| Drug Name |
2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine
|
|||
| Synonyms |
CHEMBL495543; 2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H25NO3
|
|||
| Canonical SMILES |
CCOC1=CC=CC=C1OCC2CN(CCO2)C(C)C
|
|||
| InChI |
1S/C16H25NO3/c1-4-18-15-7-5-6-8-16(15)20-12-14-11-17(13(2)3)9-10-19-14/h5-8,13-14H,4,9-12H2,1-3H3
|
|||
| InChIKey |
YIUUQQVMBNHWQV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2-Aryloxymethylmorpholine histamine H(3) antagonists. Bioorg Med Chem Lett. 2008 Nov 1;18(21):5796-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.